In conclusion, KL-6 was demonstrated to be a reliable, non-invasive, and easy-to-perform marker of interstitial lung involvement in AAV patients, being helpful for assessment of disease activity. This evidence concerns the gene MUC1 and anti-neutrophil cytoplasmic antibody-associated vasculitis.